Ubiquitination assay confirmed that both EZH2 and MYC underwent ubiquitination followed by degradation mediated by squamocin treatment in GC and CRC cell lines (Figure S7F,G, Supporting Information). The gene discussed is MYC; the disease is gastric cancer.